DETEKTION EINER NUCLEOTIDVARIATION EINER NUCLEINSÄUREZIELSEQUENZ DURCH PTO-SPALTUNG UND EXTENSIONSTEST

European patent · EP2823061 · In force

Register entry

Publication number
EP2823061
Application number
EP13757737
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Feb 25, 2013
Published
Jan 14, 2015
Granted
Feb 14, 2018
Protection ends at the latest
Feb 24, 2033
Next annual fee due
Feb 28, 2027
IPC classes
C12Q 1/68 (2018.01)
C12N 15/11 (2006.01)
G01N 33/50 (2006.01)
G01N 33/58 (2006.01)
Priority
US 201261606713 P 05.03.2012
US 201261613195 P 20.03.2012
US 201261668628 P 06.07.2012
PCT application
PCT/KR2013/001492 25.02.2013
PCT publication
WO2013/133561 12.09.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 1, 2026

    Change

    Published in Swissreg on 01.03.2026

  2. Mar 1, 2025

    Change

    Published in Swissreg on 01.03.2025

  3. Mar 1, 2024

    Change

    Published in Swissreg on 01.03.2024

  4. Mar 6, 2023

    Change

    Published in Swissreg on 06.03.2023

  5. May 2, 2018

    Agent entered

    Representative
    BOVARD AG, Patent- und Markenanwälte, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 02.05.2018

  6. Feb 14, 2018

    Granted

    Published in Swissreg on 14.02.2018

Parties

Holder

Seegene, Inc.

8Fl, 9Fl Taewon Bldg. 65-5, Bangi-dong Songpa-gu, Seoul 138-050, KR

Agent

Bovard AG

BOVARD AG Patent- und Markenanwälte

Optingenstrasse 16, 3013 Bern

Inventor

CHUN, Jong Yoon

Seoul 135-100, KR

LEE, Young Jo

Seoul 138-240, KR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.